14 April 2025
Welcoming New Editorial Board Members of Cancers Joined in February 2025
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to announce that seven new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694), joining in February 2025. We wish our new members success in both their research and their efforts to develop the journal.
Name: Prof. Dr. Muy-Teck Teh
Affiliation: 1 Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts; 2 The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Interests: molecular diagnostics; cancer biomarkers; transcriptomics; foxm1; qmids digital cancer test
Name: Prof. Dr. Thomas Ming Swi Chang
Affiliation: 1 Artificial Cells and Organs Research Centre, Faculty of Medicine and Medical Sciences; 2 McGill University, Montreal, QC H3G1Y6, Canada
Interests: artificial cells; biomaterials; blood substitutes; drug delivery; microencapsulation; enzyme engineering
Name: Dr. Dario Baratti
Affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Interests: hyperthermic intraperitoneal chemotherapy; cytoreductive surgery; peritoneum tumor; peritoneal malignancies; colorectal cancer
Name: Dr. Chiara Laezza
Affiliation: Consiglio Nazionale delle Ricerche, IEOS, CNR, 80145 Naples, Italy
Interests: mevalonate pathway; prenylation proteins; cannabinoid and cancer; cell cycle; cancer-related biochemical pathways; cell proliferation; cell signaling; breast cancer; glioblastoma multiforme
Name: Prof. Dr. Cesare Gridelli
Affiliation: Division of Medical Oncology, S.G. Moscati Hospital, 83100 Avellino, Italy
Interests: lung cancer; non-small cell lung cancer; targeted therapies; immunotherapy
Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.
Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office and provide the following files: